Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Author Correction: AI-guided precision parenteral nutrition for neonatal intensive care units.

  • Read more about Author Correction: AI-guided precision parenteral nutrition for neonatal intensive care units.

AI-guided precision parenteral nutrition for neonatal intensive care units.

  • Read more about AI-guided precision parenteral nutrition for neonatal intensive care units.

Oral obeldesivir provides postexposure protection against Marburg virus in nonhuman primates.

  • Read more about Oral obeldesivir provides postexposure protection against Marburg virus in nonhuman primates.

Impact of doxycycline post-exposure prophylaxis for sexually transmitted infections on the gut microbiome and antimicrobial resistome.

  • Read more about Impact of doxycycline post-exposure prophylaxis for sexually transmitted infections on the gut microbiome and antimicrobial resistome.

Author Correction: Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis.

  • Read more about Author Correction: Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis.

Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.

  • Read more about Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.

Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation.

  • Read more about Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation.

Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine.

  • Read more about Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine.

Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.

  • Read more about Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.

Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer.

  • Read more about Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer.

Pagination

  • Page 1
  • Next page ››
Subscribe to Nature medicine

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List